Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
10 participants
INTERVENTIONAL
2025-10-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. Does the device improve the appearance of striae distensae?
2. Does the device cause any problems when treating striae distensae? Researchers will compare the appearance of striae distensae before and after treatment with the device.
Participants will:
1. Undergo treatment with the device in the clinic
2. Visit the clinic 1 week, 3 months, and 1 year for checkups and tests
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Keratosis Pilaris With 810 nm Diode Laser
NCT01281644
Multiclear Treatment for Striae Distensae - A Pilot Study
NCT02126566
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
NCT03846531
Nonablative Fractional Diode Laser for Treatment of Skin Resurfacing and Pigmented Lesions
NCT04203745
Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin
NCT05461755
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Striae Distensae Treatment
Striae Distensae Treatment With A Device
Striae Distensae Treatment Device
One time deep skin treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Striae Distensae Treatment Device
One time deep skin treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Children's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arin Greene
Professor of Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arin Greene, MD
Role: PRINCIPAL_INVESTIGATOR
Boston Children's Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-P00051021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.